Contact Information

37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG

We Are Available 24/ 7. Call Now.
Freeport-McMoRan (FCX) Declares $0.08 Dividend
Business

Wells Fargo Initiates Coverage of UDR (UDR) with Overweight Recommendation

On March 29, 2023, Wells Fargo initiated coverage of UDR with a Overweight recommendation. Analyst Price Forecast Suggests 23.08% Upside As of March 28, 2023,

Freeport-McMoRan (FCX) Declares $0.08 Dividend
Business

Oppenheimer Initiates Coverage of Trane Technologies (TT) with Perform Recommendation

On March 28, 2023, Oppenheimer initiated coverage of Trane Technologies with a Perform recommendation. Analyst Price Forecast Suggests 8.38% Upside As of March 29, 2023,

Freeport-McMoRan (FCX) Declares $0.08 Dividend
Stock Market

Benchmark Initiates Coverage of Repligen (RGEN) with Buy Recommendation

On March 28, 2023, Benchmark initiated coverage of Repligen with a Buy recommendation. Analyst Price Forecast Suggests 23.54% Upside As of March 29, 2023, the

Freeport-McMoRan (FCX) Declares $0.08 Dividend
Stock Market

Evercore ISI Group Initiates Coverage of Astria Therapeutics (ATXS) with Outperform Recommendation

On March 28, 2023, Evercore ISI Group initiated coverage of Astria Therapeutics with a Outperform recommendation. Analyst Price Forecast Suggests 114.24% Upside As of March

Freeport-McMoRan (FCX) Declares $0.08 Dividend
Stock Market

B of A Securities Initiates Coverage of Foghorn Therapeutics (FHTX) with Buy Recommendation

On March 28, 2023, B of A Securities initiated coverage of Foghorn Therapeutics with a Buy recommendation. Analyst Price Forecast Suggests 254.32% Upside As of

Freeport-McMoRan (FCX) Declares $0.08 Dividend
Stock Market

Oppenheimer Initiates Coverage of Lennox International (LII) with Perform Recommendation

On March 28, 2023, Oppenheimer initiated coverage of Lennox International with a Perform recommendation. Analyst Price Forecast Suggests 11.24% Upside As of March 28, 2023,

Freeport-McMoRan (FCX) Declares $0.08 Dividend
Stock Market

B. Riley Securities Initiates Coverage of Gritstone Oncology (GRTS) with Buy Recommendation

On March 28, 2023, B. Riley Securities initiated coverage of Gritstone Oncology with a Buy recommendation. Analyst Price Forecast Suggests 259.88% Upside As of March

Freeport-McMoRan (FCX) Declares $0.08 Dividend
Stock Market

Morgan Stanley Initiates Coverage of Model N (MODN) with Overweight Recommendation

On March 27, 2023, Morgan Stanley initiated coverage of Model N with a Overweight recommendation. Analyst Price Forecast Suggests 51.64% Upside As of March 26,

Freeport-McMoRan (FCX) Declares $0.08 Dividend
Business

RBC Capital Initiates Coverage of Legend Biotech (LEGN) with Outperform Recommendation

On March 24, 2023, RBC Capital initiated coverage of Legend Biotech with a Outperform recommendation. Analyst Price Forecast Suggests 57.86% Upside As of March 25,